Skip to content

EPS (Basic) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.44+11.3%
Danaher logo
DanaherDHR
$1.45+9.0%
Azenta logo
AzentaAZTA
-$3.49-236%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$0.69+40.8%
TEC
Bio-TechneTECH
$0.33+136%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-$0.25+10.7%

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's EPS (basic)?
BioLife Solutions (BLFS) reported EPS (basic) of $0.02 in Q1 2026.
How has BioLife Solutions's EPS (basic) changed year-over-year?
BioLife Solutions's EPS (basic) increased by 300.0% year-over-year, from -$0.01 to $0.02.
What is the long-term trend for BioLife Solutions's EPS (basic)?
Over 2 years (2021 to 2023), BioLife Solutions's EPS (basic) has grown at a 154.1% compound annual growth rate (CAGR), from -$0.24 to -$1.55.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.